8-chloro-cyclic adenosine monophosphate has been researched along with transforming growth factor beta in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertherat, J; Bouizar, Z; Hortane, M; Ragazzon, B; Rizk-Rabin, M; Viou, L | 1 |
1 other study(ies) available for 8-chloro-cyclic adenosine monophosphate and transforming growth factor beta
| Article | Year |
|---|---|
8Cl-cAMP modifies the balance between PKAR1 and PKAR2 and modulates the cell cycle, growth and apoptosis in human adrenocortical H295R cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenal Cortex; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclic AMP-Dependent Protein Kinase RIalpha Subunit; Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit; Cyclin-Dependent Kinase 2; DNA Replication; Humans; Proliferating Cell Nuclear Antigen; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2010 |